Bio-Rad Laboratories (BIO-B) Other Non-Current Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Other Non-Current Liabilities data on file, last reported at $198.4 million in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 14.62% year-over-year to $198.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198.4 million (up 14.62% YoY) and the FY2025 annual result came in at $199.1 million, up 12.36% from the prior year.
• Other Non-Current Liabilities held at $198.4 million in Q1 2026 per BIO-B's latest filing, from $199.1 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $209.6 million in Q2 2025 and bottomed at $173.1 million in Q1 2025.
• The 5-year median for Other Non-Current Liabilities is $195.9 million (2022), against an average of $193.5 million.
• The widest annual swing landed in 2022, when Other Non-Current Liabilities decreased 21.31%; it then climbed 14.62% in 2026.
• Tracing BIO-B's Other Non-Current Liabilities over 5 years: stood at $195.9 million in 2022, then retreated by 0.47% to $195.0 million in 2023, then declined by 9.13% to $177.2 million in 2024, then gained by 12.36% to $199.1 million in 2025, then slipped by 0.35% to $198.4 million in 2026.
• Per Business Quant, the three latest BIO-B Other Non-Current Liabilities figures stand at $198.4 million (Q1 2026), $199.1 million (Q4 2025), and $207.5 million (Q3 2025).

Peer Comparison